Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(8):1091–1097. doi: 10.1038/bjc.1997.189

Histamine-stimulated expression of insulin-like growth factors in human glioma cells.

L T Van der Ven 1, S C Van Buul-Offers 1, T Gloudemans 1, P J Roholl 1, J S Sussenbach 1, W Den Otter 1
PMCID: PMC2222785  PMID: 9099954

Abstract

Glioma tumour growth is associated with the expression of insulin-like growth factors I and II (IGFs) and of both type I and type II IGF receptors. It has also been shown that IGFs can stimulate proliferation of cultured glioma cells. We previously reported that histamine too can stimulate the growth of glioma cells in vitro. In this report, we study whether the histamine-induced growth of G47 glioma cells is mediated by the IGFs. We found that histamine stimulates the expression of both IGF-I and IGF-II mRNAs, as determined by a semiquantitative in situ hybridization analysis. Furthermore, incubation of G47 cells with histamine also induced cellular immunostaining for IGF-II. It could be shown that IGF-I-stimulated proliferation is inhibited by IGFBP-3, which decreases the availability of IGFs for binding to the IGF receptors, and by beta-galactosidase, which may decrease IGF binding to the type II IGF receptor, but is not inhibited by the anti-type I IGF receptor monoclonal antibody alphaIR3. However, neither IGFBP-3 nor beta-galactosidase nor alphaIR3 inhibited the histamine-induced proliferation. These results show that the growth-stimulatory effect of histamine is accompanied by the induction of IGFs. This histamine-induced growth stimulation is not mediated by activation of cell surface IGF receptors, although intracrine activation of type II IGF receptors may be involved.

Full text

PDF
1092

Images in this article

1093Figure 2
on p.1093

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoniades H. N., Galanopoulos T., Neville-Golden J., Maxwell M. Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer. 1992 Jan 21;50(2):215–222. doi: 10.1002/ijc.2910500210. [DOI] [PubMed] [Google Scholar]
  2. Auletta M., Nielsen F. C., Gammeltoft S. Receptor-mediated endocytosis and degradation of insulin-like growth factor I and II in neonatal rat astrocytes. J Neurosci Res. 1992 Jan;31(1):14–20. doi: 10.1002/jnr.490310103. [DOI] [PubMed] [Google Scholar]
  3. Chernausek S. D. Insulin-like growth factor-I (IGF-I) production by astroglial cells: regulation and importance for epidermal growth factor-induced cell replication. J Neurosci Res. 1993 Feb 1;34(2):189–197. doi: 10.1002/jnr.490340206. [DOI] [PubMed] [Google Scholar]
  4. Cricco G. P., Davio C. A., Martin G., Engel N., Fitzsimons C. P., Bergoc R. M., Rivera E. S. Histamine as an autocrine growth factor in experimental mammary carcinomas. Agents Actions. 1994 Nov;43(1-2):17–20. doi: 10.1007/BF02005757. [DOI] [PubMed] [Google Scholar]
  5. De Leon D. D., Wilson D. M., Powers M., Rosenfeld R. G. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors. 1992;6(4):327–336. doi: 10.3109/08977199209021544. [DOI] [PubMed] [Google Scholar]
  6. Fournier B., Ferralli J. M., Price P. A., Schlaeppi J. M. Comparison of the effects of insulin-like growth factors-I and -II on the human osteosarcoma cell line OHS-4. J Endocrinol. 1993 Jan;136(1):173–180. doi: 10.1677/joe.0.1360173. [DOI] [PubMed] [Google Scholar]
  7. Fujimoto M., Kimata H. Histamine inhibits immunoglobulin production via histamine H2 receptors without affecting cell growth in human B cells. Clin Immunol Immunopathol. 1994 Oct;73(1):96–102. doi: 10.1006/clin.1994.1174. [DOI] [PubMed] [Google Scholar]
  8. Glick R. P., Gettleman R., Patel K., Lakshman R., Tsibris J. C. Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects. Neurosurgery. 1989 Jun;24(6):791–797. doi: 10.1227/00006123-198906000-00001. [DOI] [PubMed] [Google Scholar]
  9. Glick R. P., Unterman T. G., Hollis R. Radioimmunoassay of insulin-like growth factors in cyst fluid of central nervous system tumors. J Neurosurg. 1991 Jun;74(6):972–978. doi: 10.3171/jns.1991.74.6.0972. [DOI] [PubMed] [Google Scholar]
  10. Glick R. P., Unterman T. G., Van der Woude M., Blaydes L. Z. Insulin and insulin-like growth factors in central nervous system tumors. Part V: Production of insulin-like growth factors I and II in vitro. J Neurosurg. 1992 Sep;77(3):445–450. doi: 10.3171/jns.1992.77.3.0445. [DOI] [PubMed] [Google Scholar]
  11. Hellstrand K., Hermodsson S. Cell-to-cell mediated inhibition of natural killer cell proliferation by monocytes and its regulation by histamine H2-receptors. Scand J Immunol. 1991 Dec;34(6):741–752. doi: 10.1111/j.1365-3083.1991.tb01599.x. [DOI] [PubMed] [Google Scholar]
  12. Jansen J., van Buul-Offers S. C., Hoogerbrugge C. M., Van Den Brande J. L. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies. Biochem J. 1990 Mar 1;266(2):513–520. doi: 10.1042/bj2660513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jansen M., van Schaik F. M., Ricker A. T., Bullock B., Woods D. E., Gabbay K. H., Nussbaum A. L., Sussenbach J. S., Van den Brande J. L. Sequence of cDNA encoding human insulin-like growth factor I precursor. Nature. 1983 Dec 8;306(5943):609–611. doi: 10.1038/306609a0. [DOI] [PubMed] [Google Scholar]
  14. Kahlson G., Rosengren E. New approaches to the physiology of histamine. Physiol Rev. 1968 Jan;48(1):155–196. doi: 10.1152/physrev.1968.48.1.155. [DOI] [PubMed] [Google Scholar]
  15. Kato H., Faria T. N., Stannard B., Roberts C. T., Jr, LeRoith D. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3). J Biol Chem. 1993 Feb 5;268(4):2655–2661. [PubMed] [Google Scholar]
  16. Kiess W., Thomas C. L., Sklar M. M., Nissley S. P. Beta-galactosidase decreases the binding affinity of the insulin-like-growth-factor-II/mannose-6-phosphate receptor for insulin-like-growth-factor II. Eur J Biochem. 1990 May 31;190(1):71–77. doi: 10.1111/j.1432-1033.1990.tb15547.x. [DOI] [PubMed] [Google Scholar]
  17. Kikuchi K., Kadono T., Takehara K. Effects of various growth factors and histamine on cultured keloid fibroblasts. Dermatology. 1995;190(1):4–8. doi: 10.1159/000246625. [DOI] [PubMed] [Google Scholar]
  18. Klempt M., Hutchins A. M., Gluckman P. D., Skinner S. J. IGF binding protein-2 gene expression and the location of IGF-I and IGF-II in fetal rat lung. Development. 1992 Jul;115(3):765–772. doi: 10.1242/dev.115.3.765. [DOI] [PubMed] [Google Scholar]
  19. Logan A. Intracrine regulation at the nucleus--a further mechanism of growth factor activity? J Endocrinol. 1990 Jun;125(3):339–343. doi: 10.1677/joe.0.1250339. [DOI] [PubMed] [Google Scholar]
  20. Lowe W. L., Jr, Meyer T., Karpen C. W., Lorentzen L. R. Regulation of insulin-like growth factor I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor. Endocrinology. 1992 May;130(5):2683–2691. doi: 10.1210/endo.130.5.1572288. [DOI] [PubMed] [Google Scholar]
  21. Macaulay V. M. Insulin-like growth factors and cancer. Br J Cancer. 1992 Mar;65(3):311–320. doi: 10.1038/bjc.1992.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mathieu M., Rochefort H., Barenton B., Prebois C., Vignon F. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol. 1990 Sep;4(9):1327–1335. doi: 10.1210/mend-4-9-1327. [DOI] [PubMed] [Google Scholar]
  23. McCusker R. H., Camacho-Hubner C., Bayne M. L., Cascieri M. A., Clemmons D. R. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol. 1990 Aug;144(2):244–253. doi: 10.1002/jcp.1041440210. [DOI] [PubMed] [Google Scholar]
  24. Melino G., Stephanou A., Annicchiarico-Petruzzelli M., Finazzi-Agró A., Knight R. A., Lightman S. L. IGF-II mRNA expression in LI human glioblastoma cell line parallels cell growth. Neurosci Lett. 1992 Sep 14;144(1-2):25–28. doi: 10.1016/0304-3940(92)90707-e. [DOI] [PubMed] [Google Scholar]
  25. Merrill M. J., Edwards N. A. Insulin-like growth factor-I receptors in human glial tumors. J Clin Endocrinol Metab. 1990 Jul;71(1):199–209. doi: 10.1210/jcem-71-1-199. [DOI] [PubMed] [Google Scholar]
  26. Merétey K., Falus A., Taga T., Kishimoto T. Histamine influences the expression of the interleukin-6 receptor on human lymphoid, monocytoid and hepatoma cell lines. Agents Actions. 1991 May;33(1-2):189–191. doi: 10.1007/BF01993163. [DOI] [PubMed] [Google Scholar]
  27. Nissley P., Lopaczynski W. Insulin-like growth factor receptors. Growth Factors. 1991;5(1):29–43. doi: 10.3109/08977199109000269. [DOI] [PubMed] [Google Scholar]
  28. Panettieri R. A., Yadvish P. A., Kelly A. M., Rubinstein N. A., Kotlikoff M. I. Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J Physiol. 1990 Dec;259(6 Pt 1):L365–L371. doi: 10.1152/ajplung.1990.259.6.L365. [DOI] [PubMed] [Google Scholar]
  29. Pollack I. F., Randall M. S., Kristofik M. P., Kelly R. H., Selker R. G., Vertosick F. T., Jr Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg. 1991 Aug;75(2):284–293. doi: 10.3171/jns.1991.75.2.0284. [DOI] [PubMed] [Google Scholar]
  30. Richtsmeier W. J., Styczynski P., Johns M. E. Selective, histamine-mediated immunosuppression in laryngeal cancer. Ann Otol Rhinol Laryngol. 1987 Sep-Oct;96(5):569–572. doi: 10.1177/000348948709600518. [DOI] [PubMed] [Google Scholar]
  31. Roth R. A., Steele-Perkins G., Hari J., Stover C., Pierce S., Turner J., Edman J. C., Rutter W. J. Insulin and insulin-like growth factor receptors and responses. Cold Spring Harb Symp Quant Biol. 1988;53(Pt 1):537–543. doi: 10.1101/sqb.1988.053.01.062. [DOI] [PubMed] [Google Scholar]
  32. Schneider E., Piquet-Pellorce C., Dy M. New role for histamine in interleukin-3-induced proliferation of hematopoietic stem cells. J Cell Physiol. 1990 May;143(2):337–343. doi: 10.1002/jcp.1041430218. [DOI] [PubMed] [Google Scholar]
  33. Schofield P. N. Molecular biology of the insulin-like growth factors: gene structure and expression. Acta Paediatr Scand Suppl. 1991;372:83–91. doi: 10.1111/j.1651-2227.1991.tb17977.x. [DOI] [PubMed] [Google Scholar]
  34. Simmen F. A. Expression of the insulin-like growth factor-I gene and its products: complex regulation by tissue specific and hormonal factors. Domest Anim Endocrinol. 1991 Apr;8(2):165–178. doi: 10.1016/0739-7240(91)90053-m. [DOI] [PubMed] [Google Scholar]
  35. Steele-Perkins G., Turner J., Edman J. C., Hari J., Pierce S. B., Stover C., Rutter W. J., Roth R. A. Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem. 1988 Aug 15;263(23):11486–11492. [PubMed] [Google Scholar]
  36. Tilly B. C., Tertoolen L. G., Remorie R., Ladoux A., Verlaan I., de Laat S. W., Moolenaar W. H. Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors. J Cell Biol. 1990 Apr;110(4):1211–1215. doi: 10.1083/jcb.110.4.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Trojan J., Johnson T. R., Rudin S. D., Ilan J., Tykocinski M. L., Ilan J. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science. 1993 Jan 1;259(5091):94–97. doi: 10.1126/science.8418502. [DOI] [PubMed] [Google Scholar]
  38. Unterman T. G., Glick R. P., Waites G. T., Bell S. C. Production of insulin-like growth factor-binding proteins by human central nervous system tumors. Cancer Res. 1991 Jun 1;51(11):3030–3036. [PubMed] [Google Scholar]
  39. Uçar K. The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture. Biochem Biophys Res Commun. 1991 May 31;177(1):545–550. doi: 10.1016/0006-291x(91)92018-f. [DOI] [PubMed] [Google Scholar]
  40. Vannier E., Dinarello C. A. Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. J Biol Chem. 1994 Apr 1;269(13):9952–9956. [PubMed] [Google Scholar]
  41. Vannier E., Miller L. C., Dinarello C. A. Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors. J Exp Med. 1991 Jul 1;174(1):281–284. doi: 10.1084/jem.174.1.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. van Buul-Offers S. C., Reijnen-Gresnigt M. G., Hoogerbrugge C. M., Bloemen R. J., Kuper C. F., Van den Brande J. L. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice. Endocrinology. 1994 Sep;135(3):977–985. doi: 10.1210/endo.135.3.7520865. [DOI] [PubMed] [Google Scholar]
  43. van der Ven L. T., Gloudemans T., Roholl P. J., van Buul-Offers S. C., Bladergroen B. A., Welters M. J., Sussenbach J. S., den Otter W. Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I. Int J Cancer. 1994 Nov 1;59(3):427–434. doi: 10.1002/ijc.2910590323. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES